Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Assets (2020 - 2025)

Historic Assets for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $85.2 million.

  • Journey Medical's Assets rose 3301.95% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.2 million, marking a year-over-year increase of 3301.95%. This contributed to the annual value of $80.2 million for FY2024, which is 441.39% up from last year.
  • Per Journey Medical's latest filing, its Assets stood at $85.2 million for Q3 2025, which was up 3301.95% from $81.2 million recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's Assets peaked at $120.9 million during Q1 2022, and registered a low of $64.0 million during Q3 2024.
  • Over the past 5 years, Journey Medical's median Assets value was $85.0 million (recorded in 2025), while the average stood at $86.5 million.
  • Its Assets has fluctuated over the past 5 years, first surged by 8742.34% in 2021, then tumbled by 3904.67% in 2023.
  • Quarter analysis of 5 years shows Journey Medical's Assets stood at $97.3 million in 2021, then increased by 8.1% to $105.2 million in 2022, then dropped by 26.92% to $76.8 million in 2023, then increased by 4.41% to $80.2 million in 2024, then increased by 6.17% to $85.2 million in 2025.
  • Its last three reported values are $85.2 million in Q3 2025, $81.2 million for Q2 2025, and $85.0 million during Q1 2025.